Ryota Kikuchi Selected Research

Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)

5/2022

Surfactant protein D: A useful biomarker for distinguishing COVID-19 pneumonia from COVID-19 pneumonia-like diseases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ryota Kikuchi Research Topics

Disease

6	Neoplasms (Cancer) 12/2021 - 03/2010
5	Lung Neoplasms (Lung Cancer) 01/2021 - 01/2017
4	Pneumonia (Pneumonitis) 04/2024 - 01/2015
4	COVID-19 05/2022 - 12/2020
4	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2022 - 01/2021
3	Inflammation (Inflammations) 01/2021 - 05/2015
3	Acidosis 12/2020 - 11/2017
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2021
2	Asthma (Bronchial Asthma) 10/2021 - 10/2016
2	Chronic Obstructive Pulmonary Disease (COPD) 10/2021 - 10/2016
2	Dyspnea (Shortness of Breath) 01/2019 - 01/2015
2	Pulmonary Eosinophilia (Eosinophilic Pneumonia) 01/2019 - 03/2014
2	Hemorrhage 03/2018 - 01/2015
2	Pulmonary Emphysema 01/2017 - 08/2014
2	Fibrosis (Cirrhosis) 10/2016 - 05/2015
1	Idiopathic Pulmonary Fibrosis 03/2024
1	Hypoxia (Hypoxemia) 03/2024
1	Vasculitis (Vasculitides) 06/2022
1	Takayasu Arteritis (Arteritis, Takayasu's) 06/2022
1	Sarcopenia 01/2022
1	Weight Loss (Weight Reduction) 01/2022
1	Melanoma (Melanoma, Malignant) 12/2021
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 08/2021
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2021
1	Respiratory Insufficiency (Respiratory Failure) 12/2020
1	Chronic Disease (Chronic Diseases) 07/2020
1	Breast Neoplasms (Breast Cancer) 01/2019
1	Encephalitis (Encephalitis, Rasmussen) 01/2019
1	Fever (Fevers) 01/2019
1	Virus Diseases (Viral Diseases) 01/2019
1	Chronic Hepatitis C 01/2019
1	Pulmonary Edema 03/2018
1	Biliary Atresia 02/2018
1	Hypertrophy 11/2017
1	Hypercapnia 11/2017
1	Hypocapnia 11/2017

Drug/Important Bio-Agent (IBA)

3	C-Reactive ProteinIBA 01/2021 - 01/2015
3	Proteins (Proteins, Gene)FDA Link 12/2020 - 11/2017
3	Peptides (Polypeptides)IBA 01/2019 - 03/2010
3	Messenger RNA (mRNA)IBA 11/2013 - 03/2010
2	SteroidsIBA 04/2024 - 01/2019
2	Oxygen (Dioxygen)IBA 03/2024 - 11/2017
2	Biomarkers (Surrogate Marker)IBA 05/2022 - 01/2022
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 08/2021 - 11/2017
2	AlbuminsIBA 01/2021 - 01/2021
2	Adenosine Triphosphate (ATP)IBA 12/2020 - 11/2010
2	Glucose (Dextrose)FDA LinkGeneric 12/2020 - 01/2017
2	Antiviral Agents (Antivirals)IBA 01/2019 - 11/2010
2	Pancreatic Elastase (Elastase)IBA 01/2017 - 08/2014
2	AntigensIBA 01/2015 - 03/2014
2	Multidrug Resistance-Associated ProteinsIBA 11/2013 - 03/2010
2	AnionsIBA 11/2013 - 03/2010
1	Immune Checkpoint InhibitorsIBA 04/2024
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 04/2024
1	Antifibrotic AgentsIBA 03/2024
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 06/2022
1	Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA 05/2022
1	4- (3'- (2'- chlorophenyl)- 2'- propen- 1'- ylidene)- 1- phenyl- 3,5- pyrazolidinedioneIBA 01/2022
1	Interferon Type IIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	SOXE Transcription FactorsIBA 12/2021
1	Histone Deacetylase InhibitorsIBA 12/2021
1	OvalbuminIBA 10/2021
1	GlucocorticoidsIBA 10/2021
1	Dexamethasone (Maxidex)FDA LinkGeneric 10/2021
1	Therapeutic UsesIBA 10/2021
1	SmokeIBA 10/2021
1	RoflumilastIBA 10/2021
1	PPAR alphaIBA 08/2021
1	LipidsIBA 08/2021
1	Fenofibrate (CiL)FDA LinkGeneric 08/2021
1	favipiravirIBA 12/2020
1	3- (5- tert- butylisoxazol- 3- yl)- 2- ((3- chlorophenyl)hydrazono)- 3- oxopropionitrileIBA 12/2020
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 12/2020
1	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2020
1	Polymyxin B (Aerosporin)FDA LinkGeneric 12/2020
1	Ferritins (Ferritin)IBA 12/2020
1	Cisplatin (Platino)FDA LinkGeneric 01/2019
1	NivolumabIBA 01/2019
1	Antineoplastic Agents (Antineoplastics)IBA 01/2019
1	glecaprevir and pibrentasvirIBA 01/2019
1	Etoposide (VP 16)FDA LinkGeneric 01/2019
1	Carboplatin (JM8)FDA LinkGeneric 01/2019
1	Oxidants (Oxidizing Agents)IBA 01/2019
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2019
1	Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)IBA 01/2019
1	Organic Anion TransportersIBA 01/2019
1	Sitagliptin Phosphate (Januvia)FDA Link 03/2018
1	CCAAT-Enhancer-Binding ProteinsIBA 11/2017
1	Transcription Factors (Transcription Factor)IBA 11/2017
1	Adenosine Monophosphate (AMP)IBA 11/2017

Therapy/Procedure

6	Therapeutics 03/2024 - 03/2016
4	Drug Therapy (Chemotherapy) 01/2022 - 12/2020
1	Immunotherapy 12/2021
1	Plasma Exchange 01/2021
1	Transition to Adult Care 07/2020
1	Patient Transfer (Patient Dumping) 07/2020
1	Transitional Care 07/2020
1	Renal Dialysis (Hemodialysis) 01/2019
1	Liver Transplantation 02/2018